A U.S. district judge said he will vacate a declaration by Kennedy that asserted gender-affirming care for young trans people does not meet medical standards of care.
A group of autism scientists kicked off efforts Thursday to influence Congress, and the research agendas of private organizations.
Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...
Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount platform, TrumpRx, while speaking at a STAT event on Thursday.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox ...
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries to claw back market share with its ...
Meanwhile, a Jennifer Doudna-founded company is edging toward successful CAR-T therapy done in vivo, and a “triple-G” drug from Eli Lilly delivers strong results. Lastly, don’t forget that today is ...
Plus: A biotech turns to wearables and a drug giant beefs up on AI chips.
In today's Morning Rounds newsletter: the precarious state of U.S. science, what we take for granted about vaccines, and more.
Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results